Показано 0 из 0
Дата |
---|
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
39.60
|
39.45
|
40.15
|
39.60
|
|
|
920 012.32
|
|
|
|
40.40
|
39.05
|
40.40
|
39.50
|
|
|
1 411 077.12
|
|
|
|
40.25
|
39.50
|
40.50
|
40.20
|
|
|
1 232 423.95
|
|
|
|
40.60
|
40.25
|
40.65
|
40.30
|
|
|
632 054.46
|
|
|
|
40.80
|
40.25
|
41.00
|
40.25
|
|
|
902 276.95
|
|
|
|
41.35
|
40.55
|
41.35
|
40.55
|
|
|
1 397 844.74
|
|
|
|
41.50
|
40.65
|
41.50
|
41.25
|
|
|
1 801 129.68
|
|
|
|
41.05
|
40.90
|
41.80
|
40.90
|
|
|
1 558 732.15
|
|
|
|
41.35
|
40.75
|
42.15
|
40.75
|
|
|
1 592 327.09
|
|
|
|
41.70
|
41.25
|
42.20
|
41.95
|
|
|
1 550 597.07
|
|
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.